Archives
FDA Okays Chelsea's Blood Pressure Drug Northera
Chelsea Therapeutics' Northera capsule (droxidopa) is now approved for the treatment of neurogenic orthostatic hypotension (NOH), The U.S. Food and Drug Administration said Tuesday.
Latest Research Articles
NASA's Hubble Telescope Used to Calculate 250-Million-Year Revolution of Nearby Galaxy
Researchers Uncover More About European Beaver
For Children, Switching Schools Often Leads to Psychotic Symptoms
Vitamin D Proves Relief for Chronic Hives
NASA Spots 5 Million Mph Pulsar, has Longest Trail of Any Object in Galaxy
Researchers Better Understand Animal Propulsion Systems
Tulane University Announces $1 Million Prize to Combat Dead Zones in Global Waterways
Grazing Reindeer May Counter Some Climate Change Effects
Evidence Found of Early Ape Habitat
Culling is Influencing Evolution of Deadly Tasmanian Devil Facial Cancer
Low Temperature Fuel Cells Can Run on Biomass
Drought Aided the Spread of Typhus
MOST POPULAR
-
Is Yerba Mate Nature's Ozempic? Weighing In Risk Vs. Benefits
-
WATCH: 'Ed the Zebra' Airlifted Home After More than a Week on the Run in Tennessee
-
Enjoying Nature: How Outdoor Activities Can Benefit Children & Teens
-
Texas Woman Hopped on a Kayak to Escape Floodwaters With Her Dogs: 'I'm Still in Shock'
-
How Gene Editing Could Save Endangered Species from Extinction
